{"id": "tIwI6d8AAAAJ", "citedby": 94, "citedby5y": 93, "hindex": 4, "hindex5y": 4, "i10index": 1, "i10index5y": 1, "coauthors": [], "name": "Abiola Ibraheem", "affiliation": "University of chicago", "interests": ["Cancer"], "cites_per_year": {"2016": 3, "2017": 5, "2018": 17, "2019": 41, "2020": 25}, "publications": [{"bib": {"title": "Prospective international randomized phase II study of low-dose abiraterone with food versus standard dose abiraterone in castration-resistant prostate cancer", "year": "2018"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:ufrVoPGSRksC", "citedby": "62"}, {"bib": {"title": "Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: Who benefits from chemotherapy?", "year": "2019"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:u-x6o8ySG0sC", "citedby": "7"}, {"bib": {"title": "Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results", "year": "2018"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:UeHWp8X0CEIC", "citedby": "6"}, {"bib": {"title": "Improving the accrual of racial and ethnic minority patients in clinical trials: time to raise the stakes", "year": "2017"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:Tyk-4Ss8FVUC", "citedby": "4"}, {"bib": {"title": "A prospective international randomized phase II study evaluating the food effect on the pharmacokinetics (PK) and pharmacodynamics (PD) of abiraterone acetate (AA) in men with \u2026", "year": "2017"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:eQOLeE2rZwMC", "citedby": "4"}, {"bib": {"title": "Chemotherapy-induced cardiotoxicity in breast cancer patients", "year": "2016"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:YsMSGLbcyi4C", "citedby": "4"}, {"bib": {"title": "Referral patterns and clinical outcomes for transplant-eligible lymphoma and myeloma patients evaluated at an urban county hospital", "year": "2016"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:qjMakFHDy7sC", "citedby": "3"}, {"bib": {"title": "SIRFLOX: Progression-Free Survival in the Liver As a Surrogate End Point for Survival?", "year": "2016"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:2osOgNQ5qMEC", "citedby": "2"}, {"bib": {"title": "Infrastructural challenges lead to delay of curative radiotherapy in Nigeria", "year": "2020"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:5nxA0vEk-isC", "citedby": "1"}, {"bib": {"title": "Formal assessment of teamwork among cancer health care professionals in 3 large tertiary centers in Nigeria.", "year": "2017"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:u5HHmVD_uO8C", "citedby": "1"}, {"bib": {"title": "Implementing oncology clinical trials in Nigeria: A model for Capacity building.", "year": "2020"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:MXK_kJrjxJIC", "citedby": "0"}, {"bib": {"title": "Formal Assessment of Teamwork Among Cancer Health Care Professionals in Three Large Tertiary Centers in Nigeria", "year": "2020"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:hqOjcs7Dif8C", "citedby": "0"}, {"bib": {"title": "Survey of medical student knowledge in oncology and survivorship care in Nigeria: A pilot study.", "year": "2019"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:UebtZRa9Y70C", "citedby": "0"}, {"bib": {"title": "Colorectal cancer molecular subtypes by immunohistochemistry in a patient cohort from Nigeria.", "year": "2019"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:Se3iqnhoufwC", "citedby": "0"}, {"bib": {"title": "Abstract P4-08-12: Comparative analyses of the prognostic value of oncotype and mammaprint using the National Cancer Database", "year": "2019"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:Y0pCki6q_DkC", "citedby": "0"}, {"bib": {"title": "Community Clinical Practice Patterns and Mortality in Patients with Oncotype DX Intermediate Score: Who benefits from Chemotherapy?", "year": "2019"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:8k81kl-MbHgC", "citedby": "0"}, {"bib": {"title": "Infrastructural Challenges to Radiation Therapy in a Nigerian Teaching Hospital", "year": "2018"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:9yKSN-GCB0IC", "citedby": "0"}, {"bib": {"title": "Attitudes of breast cancer patients and oncology staff towards randomized clinical trials in southwest Nigeria.", "year": "2018"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:WF5omc3nYNoC", "citedby": "0"}, {"bib": {"title": "3 Questions on... Improving Cancer Survival Disparities in Minority Populations: With Abiola Ibraheem, MD, of University of Chicago Medicine", "year": "2018"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:_FxGoFyzp5QC", "citedby": "0"}, {"bib": {"title": "Abstract P1-06-05: Clinical practice and mortality in patients with oncotype DX intermediate score: What do we know about the gray zone?", "year": "2018"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:IjCSPb-OGe4C", "citedby": "0"}, {"bib": {"title": "AORTIC 2017", "year": "2017"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:LkGwnXOMwfcC", "citedby": "0"}, {"bib": {"title": "from the Experts", "year": "2017"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:roLk4NBRz8UC", "citedby": "0"}, {"bib": {"title": "Management of chemotherapy-induced thromboembolism in breast cancer", "year": "2015"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:zYLM7Y9cAGgC", "citedby": "0"}, {"bib": {"title": "Non-Inferior Clinical Outcomes for Lymphoma and Myeloma Patients Referred from a County Hospital to an Academic Transplant Center for Autologous Stem Cell Transplantation", "year": "2014"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:d1gkVwhDpl0C", "citedby": "0"}, {"bib": {"title": "RE: Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer", "year": "2014"}, "source": "citations", "id_citations": "tIwI6d8AAAAJ:W7OEmFMy1HYC", "citedby": "0"}]}